232 related articles for article (PubMed ID: 32701516)
1. Contemporary evaluation and management of tall cell variant of papillary thyroid carcinoma.
Cartwright S; Fingeret A
Curr Opin Endocrinol Diabetes Obes; 2020 Oct; 27(5):351-357. PubMed ID: 32701516
[TBL] [Abstract][Full Text] [Related]
2. Papillary Thyroid Cancer-Aggressive Variants and Impact on Management: A Narrative Review.
Coca-Pelaz A; Shah JP; Hernandez-Prera JC; Ghossein RA; Rodrigo JP; Hartl DM; Olsen KD; Shaha AR; Zafereo M; Suarez C; Nixon IJ; Randolph GW; Mäkitie AA; Kowalski LP; Vander Poorten V; Sanabria A; Guntinas-Lichius O; Simo R; Zbären P; Angelos P; Khafif A; Rinaldo A; Ferlito A
Adv Ther; 2020 Jul; 37(7):3112-3128. PubMed ID: 32488657
[TBL] [Abstract][Full Text] [Related]
3. Breast Tumor Resembling the Tall Cell Variant of Papillary Thyroid Carcinoma: Molecular Characterization by Next-Generation Sequencing and Histopathological Comparison With Tall Cell Papillary Carcinoma of Thyroid.
Zhong E; Scognamiglio T; D'Alfonso T; Song W; Tran H; Baek I; Hoda SA
Int J Surg Pathol; 2019 Apr; 27(2):134-141. PubMed ID: 30227763
[TBL] [Abstract][Full Text] [Related]
4. Expression of cancer stem cell markers in tall cell variant papillary thyroid cancer identifies a molecular profile predictive of recurrence in classic papillary thyroid cancer.
Beck AC; Rajan A; Landers S; Kelley S; Bellizzi AM; Lal G; Sugg SL; Howe JR; Chan CH; Weigel RJ
Surgery; 2022 Jan; 171(1):245-251. PubMed ID: 34362588
[TBL] [Abstract][Full Text] [Related]
5. Tall cell variant of papillary thyroid carcinoma: current evidence on clinicopathologic features and molecular biology.
Wang X; Cheng W; Liu C; Li J
Oncotarget; 2016 Jun; 7(26):40792-40799. PubMed ID: 27008708
[TBL] [Abstract][Full Text] [Related]
6. Assessment of risk factors in metastatic/recurrent tall cell variant of papillary thyroid carcinoma.
Okuyucu K; Alagoz E; Ince S; Arslan N
Endokrynol Pol; 2017; 68(6):623-630. PubMed ID: 29022644
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors in papillary microcarcinoma with emphasis on histologic subtyping: a clinicopathologic study of 148 cases.
Ghossein R; Ganly I; Biagini A; Robenshtok E; Rivera M; Tuttle RM
Thyroid; 2014 Feb; 24(2):245-53. PubMed ID: 23745671
[TBL] [Abstract][Full Text] [Related]
8. Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†.
Filetti S; Durante C; Hartl D; Leboulleux S; Locati LD; Newbold K; Papotti MG; Berruti A;
Ann Oncol; 2019 Dec; 30(12):1856-1883. PubMed ID: 31549998
[No Abstract] [Full Text] [Related]
9. Aggressive Variants of Papillary Thyroid Carcinoma: Hobnail, Tall Cell, Columnar, and Solid.
Nath MC; Erickson LA
Adv Anat Pathol; 2018 May; 25(3):172-179. PubMed ID: 29351089
[TBL] [Abstract][Full Text] [Related]
10. Clear Cell Variant of Papillary Thyroid Carcinoma With Associated Anaplastic Thyroid Carcinoma: Description of an Extraordinary Case.
Juhlin CC; Höög A
Int J Surg Pathol; 2019 Sep; 27(6):658-663. PubMed ID: 30931661
[TBL] [Abstract][Full Text] [Related]
11. The evolving concept of aggressive histological variants of differentiated thyroid cancer.
Hernandez-Prera JC
Semin Diagn Pathol; 2020 Sep; 37(5):228-233. PubMed ID: 32241577
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and prognostic significance of poor differentiation and tall cell variant in papillary carcinoma in Japan.
Ito Y; Hirokawa M; Fukushima M; Inoue H; Yabuta T; Uruno T; Kihara M; Higashiyama T; Takamura Y; Miya A; Kobayashi K; Matsuzuka F; Miyauchi A
World J Surg; 2008 Jul; 32(7):1535-43; discussion 1544-5. PubMed ID: 18224467
[TBL] [Abstract][Full Text] [Related]
13. [Poorly differentiated carcinoma of the thyroid].
Ito Y; Hirokawa M; Miyauchi A
Nihon Rinsho; 2007 Nov; 65(11):1985-90. PubMed ID: 18018559
[TBL] [Abstract][Full Text] [Related]
14. Management of differentiated thyroid cancer of the follicular epithelium.
Pacini F
Ann Med; 2012 Nov; 44(7):651-5. PubMed ID: 21668295
[TBL] [Abstract][Full Text] [Related]
15. Hobnail subtype of papillary carcinoma of the thyroid-a rare case with uncommon features.
Ramesh V; Tripathy SR; Sable M; Samal DK; Ayyanar P
Cytopathology; 2024 Mar; 35(2):296-300. PubMed ID: 37950558
[TBL] [Abstract][Full Text] [Related]
16. Changing the Cancer Diagnosis: The Case of Follicular Variant of Papillary Thyroid Cancer-Primum Non Nocere and NIFTP.
Hodak S; Tuttle RM; Maytal G; Nikiforov YE; Randolph G
Thyroid; 2016 Jul; 26(7):869-71. PubMed ID: 27184034
[No Abstract] [Full Text] [Related]
17. A comparison of the clinicopathological features and prognoses of the classical and the tall cell variant of papillary thyroid cancer: a meta-analysis.
Liu Z; Zeng W; Chen T; Guo Y; Zhang C; Liu C; Huang T
Oncotarget; 2017 Jan; 8(4):6222-6232. PubMed ID: 28009980
[TBL] [Abstract][Full Text] [Related]
18. Hobnail Variant of Papillary Thyroid Carcinoma: a Literature Review.
Ambrosi F; Righi A; Ricci C; Erickson LA; Lloyd RV; Asioli S
Endocr Pathol; 2017 Dec; 28(4):293-301. PubMed ID: 29019044
[TBL] [Abstract][Full Text] [Related]
19. The prognostic significance of tall cells in papillary thyroid carcinoma: A case-control study.
Stenman S; Siironen P; Mustonen H; Lundin J; Haglund C; Arola J
Tumour Biol; 2018 Jul; 40(7):1010428318787720. PubMed ID: 30010512
[TBL] [Abstract][Full Text] [Related]
20. Recent Advances in the Classification of Low-grade Papillary-like Thyroid Neoplasms and Aggressive Papillary Thyroid Carcinomas: Evolution of Diagnostic Criteria.
Guo Z; Ge M; Chu YH; Asioli S; Lloyd RV
Adv Anat Pathol; 2018 Jul; 25(4):263-272. PubMed ID: 29762157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
